New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
10:46 EDTIMPV, PFPT, QLYS, FEYEFireEye retreats as over 14M shares become available for sale
Today marks the first day that restricted shares of FireEye (FEYE) can be sold after the companyís initial public offering. Todayís lock-up expiration, as it is known on Wall Street, has shares of the Internet security company moving lower. WHAT'S NEW: 14.66M shares of FireEye can be sold today without the restrictions that were put in place by the companyís IPO which occurred on September 20, 2013. The first day on which shares can be sold following restrictions is referred to as the lock-up expiration day. Another 95.6M shares of FireEye will be eligible for sale after shares received by Mandiant employees are registered for resale. Fireeye bought Mandiant earlier this year. PRICE ACTION: In mid-morning trading, FireEye slumped $3.45, or 4.5%, to $74.34. Other Internet security companies also dropped, with Proofpoint (PFPT) losing 4.8% to $41.79, Imperva (IMPV) dropping 1.1% to $61.75 and Qualys (QLYS) losing 1.2% to $27.66.
News For FEYE;PFPT;IMPV;QLYS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 22, 2015
09:34 EDTFEYEActive equity options trading on open
Active equity options trading on open: AAPL BABA AMZN FB MU BIDU SDRL BAC INTC EXPE CHK FEYE
May 20, 2015
15:55 EDTQLYS, IMPV, PFPT, FEYECareFirst BlueCross BlueShield confirms cyberattack
CareFirst BlueCross BlueShield has confirmed that cyberattackers gained limited, unauthorized access to a single CareFirst database. This was discovered as a part of the companyís ongoing Information Technology security efforts in the wake of recent cyberattacks on health insurers. CareFirst engaged Mandiant, a unit of FireEye (FEYE), to conduct an end-to-end examination of its IT environment. The review determined that in June 2014 cyberattackers gained access to a single database in which CareFirst stores data that members and other individuals enter to access CareFirstís websites and online services. Approximately 1.1M current and former CareFirst members and individuals who do business with CareFirst online who registered to use CareFirstís websites prior to June 20, 2014 are affected by this event. All affected members will receive a letter from CareFirst offering two free years of credit monitoring and identity theft protection. Mandiant completed its review and found no indication of any other prior or subsequent attack or evidence that other personal information was accessed. Other publicly traded companies in the cybersecurity space include Barracuda Networks (CUDA), Check Point (CHKP), F5 Networks (FFIV), Fortinet (FTNT), Imperva (IMPV), Palo Alto (PANW), Proofpoint (PFPT), Qualys (QLYS) and Symantec (SYMC).
10:00 EDTFEYEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:14 EDTQLYS, PFPTJefferies software analysts hold an analyst/industry conference call
Subscribe for More Information
08:41 EDTPFPT, IMPV, QLYS, FEYECisco CFO sees potential for acquistions in security
Subscribe for More Information
07:36 EDTFEYEJPMorgan to hold a conference
Subscribe for More Information
06:51 EDTFEYEFireEye initiated with a Buy at Evercore ISI
Target $50.
May 19, 2015
07:13 EDTPFPTProofpoint can beat expectations over next few years, says Wells Fargo
Subscribe for More Information
05:42 EDTPFPTProofpoint added to Priority Stock List at Wells Fargo
Subscribe for More Information
May 18, 2015
09:06 EDTFEYEFireEye announces strategic alliance with ACE Group
Subscribe for More Information
09:01 EDTFEYEMarsh, FireEye announce collaboration to offer cybersecurity readiness service
Marsh (MMC) and FireEye (FEYE) announced a collaboration to offer clients Marsh Cyber OASIS. This service is designed to assists clients by providing an objective evaluation of their organizationís ability to detect and respond to cyber-attacks, and the strength of their technical infrastructure.
May 15, 2015
07:14 EDTIMPVPiper recommends buying shares of Imperva
Subscribe for More Information
May 14, 2015
14:01 EDTFEYEFireEye currently unwilling to consider sale, Re/code reports
After Cisco (CEO) John Chambers said last night on the company Q3 conference call that he "wouldn't bet on" the rumor that his company was targeting an acquisition of FireEye (FEYE), Re/code's Arik Hesseldahl added that FireEye is not for sale in any case. The security company's management would not be willing to entertain takeover offers before it reaches $1B in annual revenue, sources familiar with the matter told Hesseldahl. Reference Link
08:21 EDTPFPT, FEYEFinjan says patent suits ongoing with numerous cybersecurity companies
Finjan (FNJN) said it has an active Markman Hearing schedule with two Markman Hearings already concluded in favor of the company and two additional Markman Hearings to be held in Q2. The company has a two-week trial against Blue Coat set to commence on July 20. Finjan has patent infringement lawsuits against FireEye (FEYE), BlueCoat, Proofpoint (PFPT), Sophos, Symantec (SYMC), and Palo Alto Networks (PANW) relating to, collectively, more than 20 patents in the Finjan portfolio. Subsequent to the quarter end, Finjan entered into a negotiated license agreement with F-Secure Corporation, a company incorporated in Finland. The agreement provides for F-Secure to pay Finjan the sum of $1M in cash, to be paid in two installments, consisting of $700,000 which was received on April 22 and $300,000 on or before March 31, 2016. The agreement also provides for the assignment by F-Secure to Finjan of two patents, U.S. Patent Nos. 8,474,048 and 7,749,991.
07:56 EDTIMPVImperva outlook has improved, says RBC Capital
After marketing with Imperva's management, RBC Capital is more upbeat on the company's outlook. The firm thinks Imperva's management looks confident, while its end market has improved and it remains well-positioned within the sector. RBC keeps a $61 price target and Outperform rating on the shares.
06:46 EDTIMPVImperva price target raised to $66 from $57 at Piper Jaffray
Piper Jaffray raised its price target for Imperva to $66 after meetings with management gave it increased conviction in the company's Q2 results as well as its longer-term belief that the company is one of the best positioned vendors. Piper views the stock's valuation as "relatively cheap" and reiterates an Overweight rating on the name.
May 13, 2015
18:04 EDTFEYECisco CEO says don't bet on talk of FireEye acquisition
Subscribe for More Information
10:32 EDTFEYEFireEye calls active on renewed takeover chatter
Subscribe for More Information
10:20 EDTFEYERumor: FireEye moves up on renewed takeover chatter
Subscribe for More Information
07:21 EDTPFPT, QLYSCredit Suisse to hold a conference
4th Annual Disruptive Technology Conference is being held in San Francisco on May 13-14 with webcasted company presentations to begin on May 13 at 10:35 am; not all company presentations may be webcasted. Webcast Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use